Immunogenicity results using human papillomavirus (HPV) specific DNA vaccine, INO-3112 (HPV16/HPV18 plasmids + IL-12) in HPV+ head and neck squamous cell carcinoma (HNSCCa).

被引：17

作者：

Aggarwal, Charu

Cohen, Roger B.

Morrow, Matthew P.

Kraynyak, Kimberly

Bauml, Joshua

Weinstein, Gregory S.

Boyer, Jean

Yan, Jian

Mangrolia, Drishty

Oyola, Sandra

Duff, Susan

Weiner, David B.

Csiki, Ildiko

Bagarazzi, Mark L.

机构：

[1] Abramson Canc Ctr, Philadelphia, PA USA

[2] Univ Pennsylvania, Philadelphia, PA USA

[3] Inovio Pharmaceut Inc, Plymouth, PA USA

[4] Inovio Pharmaceut Inc, Blue Bell, PA USA

[5] Univ Pennsylvania, Perelman Sch Med, Philadelphia, PA USA

[6] Wistar Inst Anat & Biol, Philadelphia, PA USA

[7] GSK, Malvern, PA USA

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.6073

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6073

引用

页数：5